The Clinical Trials Guru's Dan Sfera on Innovation in Phase 1 Studies and Beyond
It’s no secret that pharma and bio are struggling to fill their pipelines. Dan Sfera from The Clinical Trials Guru, joins Andrea Charles from Pharma IQ to discuss specific challenges that arise in conducting Phase 1 studies and the additional skills that are required to overcome them, barriers to participation in early phase clinical trials and the potential challenges and opportunities of using biomarkers and when is the optimum time to start development.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.